(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, on Tuesday announced a multi-year extension of its limited exclusive distribution and supply agreement with THINK Surgical, an orthopedic surgical robotics company.

Zimmer Biomet Extends Limited Exclusive Distribution Agreement With THINK Surgical 

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the VanEck Morningstar Wide Moat ETF (Symbol: MOAT) where we have detected an approximate $2.9 billion dollar outflow -- that's a 20.5% decrease week ov

MOAT, LPLA, ZBH, BR: Large Outflows Detected at ETF

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Loews Corp. (Symbol: L) has taken over the #398 spot from Zimmer Biomet Holdings Inc (Symbol: ZBH), according to The Online Investor.  

	Market capitalization is an impo

Loews Takes Over #398 Spot From Zimmer Biomet Holdings

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Lennox International Inc (Symbol: LII) has taken over the #412 spot from Zimmer Biomet Holdings Inc (Symbol: ZBH), according to The Online Investor.  

	Market capitaliza

Lennox International Moves Up In Market Cap Rank, Passing Zimmer Biomet Holdings 

Zimmer Biomet Holdings, a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026. The cash dividend of $0.24 per share is payable on or about July 31, 2026

Daily Dividend Report: ZBH,SVM,BSY,TCBK,PHIN

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Zimmer Biomet Holdings, Inc. News